Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minnepura Technologies is a private environmental biotechnology company developing bacteria-based water purification solutions. Its core technology uses patented silica beads to encapsulate selected naturally occurring bacteria, allowing them to remain viable for extended periods while degrading problematic chemical contaminants in water and waste streams. The company originated from University of Minnesota research and has positioned the technology for industrial and municipal water treatment applications. Minnepura appears to operate as a platform company rather than a therapeutic drug developer, with offerings focused on contaminant-specific bioremediation and pollutant removal for sectors such as agriculture, oil and gas, pharmaceuticals, and municipal water systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minnepura Technologies.